Board certified child neurologists, Dr. Craig Zaidman and Dr. Aravindhan Veerapandiyan, discuss the importance of genetic screening and various therapeutic options for patients with DMD.
View the full activity on TFF: www.francefoundation.com/educ...
This activity is supported by an independent medical educational grant from Sarepta Therapeutics, Inc. and is intended for clinicians who have a role in the diagnosis, monitoring, and treatment of patients with DMD.
Негізгі бет Ғылым және технология Early Screening and Therapeutic Options for Patients with DMD
Пікірлер